FOOD AND DRUG ADMINISTRATION 
Center for Drug Evaluation and Research 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

 

 

February 22, 2012 

MEETING ROSTER 

 

 

David M. Capuzzi, M.D., Ph.D. 
Professor of Medicine and Biochemistry 
Thomas Jefferson University & 
Lankenau Institute for Medical Research 
Philadelphia, Pennsylvania 
 

 
DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Paul T. Tran, R.Ph  
Division of Advisory Committee and Consultant Management  
Office of Executive Programs, CDER, FDA 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS 
(Voting) 
                                                                                                  
Erica H. Brittain, Ph.D. 
Mathematical Statistician  
Biostatistics Research Branch 
National Institute of Allergy and Infectious Diseases 
(NIAID), National Institutes of Health (NIH) 
Bethesda, Maryland 
 
Eric I. Felner, M.D., MSCR 
Associate Professor of Pediatrics 
Division of Pediatric Endocrinology 
Director, Pediatric Endocrinology Fellowship 
Program 
Emory University School of Medicine 
Atlanta, Georgia 
 
Abraham Thomas, M.D., M.P.H., FACP (Chair) 
Division Head, Endocrinology, Diabetes, Bone, and 
Mineral Disorders 
Henry Ford Hospital 
Whitehouse Chair of Endocrinology 
Detroit, Michigan  
 
ACTING INDUSTRY REPRESENTATIVE TO THE COMMITTEE (Non-Voting) 
 
Mads F. Rasmussen, M.D., Ph.D. 
(Acting Industry Representative) 
Executive Director 
Diabetes - Clinical Development and Research 
Clinical Development, Medical and Regulatory 
Affairs 
Novo Nordisk Inc.  
Princeton, New Jersey 

Lamont G. Weide, M.D., Ph.D., FACE 
Chief, Diabetes & Endocrinology 
Professor, Internal Medicine  
University of Missouri - Kansas City 
Truman Medical Centers, Diabetes Center 
Kansas City, Missouri 

Edward W. Gregg, Ph.D. 
Chief, Epidemiology and Statistics Branch 
Division of Diabetes Translation 
Centers for Disease Control and Prevention (CDC) 
Atlanta, Georgia  
 

 

Page 1 of 4 

FOOD AND DRUG ADMINISTRATION 
Center for Drug Evaluation and Research 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

 

 

 

February 22, 2012 

MEETING ROSTER (cont.) 

 
TEMPORARY MEMBERS (Voting) 
 
Kenneth D. Burman, M.D.  
Chief, Endocrine Section 
Washington Hospital Center 
Washington, District of Columbia 
 

Melanie Coffin (Patient Representative) 
Washington, District of Columbia 

Katherine M. Flegal, Ph.D. 
Senior Research Scientist 
Distinguished Consultant 
National Center for Health Statistics, CDC 
Hyattsville, Maryland  
 
Jessica W. Henderson, Ph.D. 
(Acting Consumer Representative) 
Professor of Community Health Education 
Division of Health and Physical Education 
Western Oregon University 
Monmouth, Oregon 
 

Michael S. Lauer, M.D., FACC, FAHA 
Director 
Division of Cardiovascular Sciences 
National Heart, Lung, and Blood Institute 
(NHLBI), NIH 
Bethesda, Maryland 
 
 
 

Robert R. Clancy, M.D. 
Professor of Neurology and Pediatrics 
The University of Pennsylvania School of Medicine 
The Children's Hospital of Philadelphia 
Philadelphia, Pennsylvania 
 
Janet D. Cragan, M.D., M.P.H. 
National Center on Birth Defects and Developmental 
Disabilities 
Division of Birth Defects and Developmental 
Disabilities, CDC 
Atlanta, Georgia 
 
Allison B. Goldfine, M.D. 
Assistant Director of Clinical Research 
Joslin Diabetes Center, Research Division 
Boston, Massachusetts 

Sanjay Kaul, M.D. 
Director, Fellowship Training Program in 
Cardiovascular Diseases 
Cedars-Sinai Heart Institute 
Professor, David Geffen School of Medicine at UCLA 
Division of Cardiology 
Cedar Sinai Medical Center  
Los Angeles, California 
 
Elaine H. Morrato, Dr.PH., M.P.H., C.P.H. 
Assistant Professor 
Departments of Health Systems, Management & 
Policy Clinical Pharmacy and Pediatrics 
Assistant Director 
Childrenâ€™s Outcomes Research Program 
Anschutz Medical Campus 
University of Colorado-Denver 
Aurora, Colorado 
 
 

Page 2 of 4 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

FOOD AND DRUG ADMINISTRATION 
Center for Drug Evaluation and Research 

 

 

February 22, 2012 

MEETING ROSTER (cont.) 

 

 
TEMPORARY MEMBERS (Voting) 
 
Sonja A., Rasmussen, M.D., M.S. 
Deputy Director 
Influenza Coordination Unit, CDC 
Atlanta, Georgia 
 
Robert J. Smith, M.D. 
Professor of Medicine (Endocrinology) 
Alpert Medical School of Brown University 
East Providence, Rhode Island 
 

Almut G. Winterstein, Ph.D. 
Associate Professor 
Pharmaceutical Outcomes & Policy (POP)  
College of Pharmacy  
Epidemiology & Biostatistics 
College of Public Health and Health Professions 
Gainesville, Florida 
 
SPEAKER (Non-Voting) 
 
Suzanne M. Gilboa, Ph.D. 
National Center on Birth Defects and 
Developmental Disabilities, CDC 
Atlanta, Georgia 
 
FDA PARTICIPANTS (Non-Voting) 
 
John K. Jenkins, M.D. 
Director 
Office of New Drugs, CDER, FDA 
 

 

 

Michael A. Rogawski, M.D., Ph.D. 
Professor and Chair, Department of Neurology 
University of California, Davis 
Sacramento, California 
 
Myrlene A. Staten, M.D. 
Senior Advisor, Diabetes Translational Research 
Division of Diabetes, Endocrinology and Metabolism 
National Institute of Diabetes and Digestive and 
Kidney Diseases (NIDDK), NIH 
Bethesda, Maryland 
 
Susan Z. Yanovski, M.D. 
Co-Director, Office of Obesity Research 
Director, Obesity and Eating Disorders Program 
NIDDK, NIH 
Bethesda, Maryland 
 

 

 
 
Mary H. Parks, M.D. 
Director  
Division of Metabolism and Endocrinology Products 
(DMEP) 
Office of Drug Evaluation II (ODE II) 
OND, CDER, FDA 
 
 
 
 

Page 3 of 4 

FOOD AND DRUG ADMINISTRATION 
Center for Drug Evaluation and Research 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

 

 

February 22, 2012 

MEETING ROSTER (cont.) 

 

 
Eric C. Colman, M.D. 
Deputy Director 
DMEP, ODE II, OND, CDER, FDA 
 
Joyce Weaver, Pharm.D. 
Senior Drug Risk Management Analyst  
Division of Risk Management 
Office of Medication Error Prevention and Risk 
Management (OMEPRM) 
Office of Surveillance and Epidemiology (OSE) 
CDER, FDA 
 

Mary D. Roberts, M.D. 
Clinical Reviewer 
DMEP, ODE II, OND, CDER, FDA 
 
Claudia B. Karwoski, Pharm.D. 
Director, Division of Risk Management 
OMEPRM, OSE, CDER, FDA 
 

Page 4 of 4 

